[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369755-105":59,"doc-detail-369755-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","development-of-a-prognostic-model-based-on-m6a-reader-hnrnpa2b1-upregulation-and-immune-infiltration-in-multiple-malignant-tumors","Development of a prognostic model based on m6A reader HNRNPA2B1 upregulation and immune infiltration in multiple malignant tumors","","High expression of the m6A reader HNRNPA2B1 has been reported across diverse tumor types. This study investigates how HNRNPA2B1 influences pan-cancer occurrence and progression and evaluates its biological roles and molecular regulatory mechanisms. Using TCGA and GEO datasets, HNRNPA2B1-related gene expression, DNA promoter methylation, phosphorylation status, immune infiltration, and survival prognosis were analyzed, supported by immunohistochemistry validation.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-of-a-prognostic-model-based-on-m6a-reader-hnrnpa2b1-upregulation-and-immune-infiltration-in-multiple-malignant-tumors/369755/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-of-a-prognostic-model-based-on-m6a-reader-hnrnpa2b1-upregulation-and-immune-infiltration-in-multiple-malignant-tumors/369755.png","ImageObject",300,407,{"name":92,"@type":93},"supergirl","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main aim of the study?","Question",{"text":112,"@type":113},"To develop and assess a prognostic model linking m6A reader HNRNPA2B1 upregulation with immune infiltration in multiple malignant tumors, and to clarify underlying regulatory mechanisms.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were HNRNPA2B1 and related factors analyzed?",{"text":117,"@type":113},"HNRNPA2B1 gene and protein expression, TNM stage, and survival prognosis across 33 tumor types were evaluated using TCGA and GEO, with bioinformatics analyses of prognosis-related genes, DNA methylation, phosphorylation, and immune cell infiltration. Immunohistochemistry was used for confirmation.",{"name":119,"@type":110,"acceptedAnswer":120},"What key findings connect HNRNPA2B1 to cancer outcomes and immune infiltration?",{"text":121,"@type":113},"HNRNPA2B1 overexpression was associated with cancer development and poor prognosis in multiple cancers. Its expression correlated with immune infiltration in specific cohorts and was linked to DNA methylation and phosphorylation across tumor types.",{"name":123,"@type":110,"acceptedAnswer":124},"Are there potential therapeutic candidates targeting HNRNPA2B1?",{"text":125,"@type":113},"Nine Chinese herbal medicines and ten plant-derived compounds targeting HNRNPA2B1 were identified, suggesting potential therapeutic relevance alongside its prognostic value.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},369755,1790327974,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":26,"preview_page_count":19,"preview_urls":149},962088121634,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Development of a prognostic model based on m6A reader HNRNPA2B1 upregulation and immune infiltration in multiple malignant tumors  \nYang Han1, Wei Xia1,2, Zhong-Na Ma1, Zhong-Chao Mai1, Yu-Shui Ma3, Da Fu4, Juhua Zhuang1  \n1Department of Nuclear Medicine, The Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China; 2Department of Nuclear Medicine, Pudong New Area Gongli Hospital, Shanghai, China; 3Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China; 4General Surgery, Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China  \nContributions: (I) Conception and design: Y Han, W Xia, YS Ma, D Fu; (II) Administrative support: Y Han, W Xia, J Zhuang; (III) Provision of study materials or patients: Y Han, ZN Ma, J Zhuang; (IV) Collection and assembly of data: Y Han, ZN Ma, ZC Mai; (V) Data analysis and interpretation: Y Han, W Xia, YS Ma, D Fu; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.  \nCorrespondence to: Yang Han, PhD. Department of Nuclear Medicine, The Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 358 Datong Road, Pudong, Shanghai 200137, [China. Email: hymedicine@163.com](China. Email: hymedicine@163.com); Wei Xia, PhD. Department of Nuclear Medicine, The Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 358 Datong Road, Pudong, Shanghai 200137, China; Department of Nuclear Medicine, Pudong New Area Gongli Hospital, 219 Miaopu Road, Pudong, Shanghai 200135, China. Email: [awingxia@163.com](awingxia@163.com); Juhua Zhuang, MD. Department of Nuclear Medicine, The Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 358 Datong Road, Pudong, Shanghai 200137, [China. Email: hhzhuang1984@163.com](China. Email: hhzhuang1984@163.com).  \nBackground: High HNRNPA2B1 expression has been previously observed in diverse tumor types. On this basis, the present work focused on exploring the effects of HNRNPA2B1 on pan-cancer occurrence and  \nprogression, as well as its potential functions and molecular regulatory mechanisms.  \nMethods: HNRNPA2B1 gene expression, protein expression, Tumor Node Metastasis (TNM) stage, and survival prognosis in thirty-three different tumors across thirty-three tumors were analyzed via The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases, which included 9,664 cancer tissues and 711 normal tissues, with R software (version 3.6.3) . A series of bioinformatics analyses were performed to determine the relationships between the expression of HNRNPA2B1-associated genes and prognosis, DNA promoter methylation, phosphorylation status and immune cell inﬁltration. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed to elucidate gene functions. Cancer and corresponding para-cancerous samples were conﬁrmed  \nvia immunohistochemistry.  \nResults: This study conﬁrmed that HNRNPA2B1 overexpression was associated with cancer development and a dismal prognosis in multiple types of cancer. Mutation and amplification were the main types of alterations in bladder urothelial carcinoma and esophageal adenocarcinoma, respectively. The phosphorylation and methylation levels of HNRNPA2B1 were linked to multiple tumor types. Furthermore, the HNRNPA2B1 expression level was positively correlated with infiltration degree in CESC, LIHC, HNSC-HPV+, and MESO-associated ﬁbroblasts in TCGA. In addition, nine Chinese herbal medicines and  \nten Chinese medicinal plant components targeting HNRNPA2B1 were identiﬁed.  \nConclusions: HNRNPA2B1 affects tumor occurrence and progr","cbCairDEedIK3UKY","https://ap.wps.com/l/cbCairDEedIK3UKY","pdf",2927490,24,"English","# Introduction\n## Background\n# Methods\n## Pan-cancer analysis workflow\n# Results\n## Prognostic associations and molecular regulation\n## Therapeutic targeting candidates\n# Conclusions","[{\"question\":\"What is the main aim of the study?\",\"answer\":\"To develop and assess a prognostic model linking m6A reader HNRNPA2B1 upregulation with immune infiltration in multiple malignant tumors, and to clarify underlying regulatory mechanisms.\"},{\"question\":\"How were HNRNPA2B1 and related factors analyzed?\",\"answer\":\"HNRNPA2B1 gene and protein expression, TNM stage, and survival prognosis across 33 tumor types were evaluated using TCGA and GEO, with bioinformatics analyses of prognosis-related genes, DNA methylation, phosphorylation, and immune cell infiltration. Immunohistochemistry was used for confirmation.\"},{\"question\":\"What key findings connect HNRNPA2B1 to cancer outcomes and immune infiltration?\",\"answer\":\"HNRNPA2B1 overexpression was associated with cancer development and poor prognosis in multiple cancers. Its expression correlated with immune infiltration in specific cohorts and was linked to DNA methylation and phosphorylation across tumor types.\"},{\"question\":\"Are there potential therapeutic candidates targeting HNRNPA2B1?\",\"answer\":\"Nine Chinese herbal medicines and ten plant-derived compounds targeting HNRNPA2B1 were identified, suggesting potential therapeutic relevance alongside its prognostic value.\"}]","Development of a prognostic model based on m6A reader HNRNPA2B1 upregulation and immune infiltration in multiple malignant tumors | PDF",1790184363,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e1e74067849f3ad7e9f3d5919641056.webp",983,1287,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f1354a5411dc64f6db4ace7a3f7b68e.webp",982,1286,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d637b3634829803140da492ec11066a.webp",981,1284,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2225a850ba0da4ea525e90cd4ecec1d0.webp",980,1283]